Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Other Working Capital Changes (2021 - 2026)

HeartSciences' Other Working Capital Changes history spans 6 years, with the latest figure at -$206516.0 for Q1 2026.

  • For Q1 2026, Other Working Capital Changes fell 259.05% year-over-year to -$206516.0; the TTM value through Jan 2026 reached -$115015.0, down 358.28%, while the annual FY2025 figure was $2596.0, 101.1% up from the prior year.
  • Other Working Capital Changes reached -$206516.0 in Q1 2026 per HSCS's latest filing, down from $146617.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $146617.0 in Q4 2025 to a low of -$206516.0 in Q1 2026.
  • Average Other Working Capital Changes over 5 years is -$55719.1, with a median of -$60505.0 recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: plummeted 273.43% in 2022, then surged 268.0% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$130976.0 in 2022, then plummeted by 53.65% to -$201244.0 in 2023, then increased by 10.0% to -$181128.0 in 2024, then skyrocketed by 180.95% to $146617.0 in 2025, then plummeted by 240.85% to -$206516.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Other Working Capital Changes are -$206516.0 (Q1 2026), $146617.0 (Q4 2025), and -$28302.0 (Q3 2025).